NuGen Medical Devices Inc. NGMD.V
TSX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -249.40K | -1.18M | -3.73M | -1.36M | -1.68M |
| Total Depreciation and Amortization | -94.80K | 121.40K | 143.50K | 123.10K | 118.40K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -426.00K | 315.00K | 2.93M | 517.10K | 985.20K |
| Change in Net Operating Assets | -57.60K | 13.00K | -48.20K | -50.20K | 65.40K |
| Cash from Operations | -827.80K | -734.80K | -704.50K | -765.40K | -513.20K |
| Capital Expenditure | 214.80K | -216.70K | -124.80K | -54.70K | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -165.40K | -38.90K | -200.00 | -800.00 | -38.30K |
| Cash from Investing | 49.40K | -255.60K | -125.00K | -55.50K | -38.30K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | 0.00 | 0.00 | 0.00 |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | 0.00 | 0.00 | 0.00 |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -778.50K | -990.40K | -829.60K | -820.90K | -551.40K |